Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

NYSE:CXW - US21871N1019 - Common Stock

20.79 USD
+0.34 (+1.66%)
Last: 8/22/2025, 8:04:00 PM
20.46 USD
-0.33 (-1.59%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXW. CXW was compared to 84 industry peers in the Commercial Services & Supplies industry. CXW has only an average score on both its financial health and profitability. CXW has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

CXW had positive earnings in the past year.
In the past year CXW had a positive cash flow from operations.
CXW had positive earnings in 4 of the past 5 years.
CXW had a positive operating cash flow in each of the past 5 years.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

CXW has a better Return On Assets (3.39%) than 66.67% of its industry peers.
With a decent Return On Equity value of 7.04%, CXW is doing good in the industry, outperforming 63.10% of the companies in the same industry.
CXW's Return On Invested Capital of 5.45% is in line compared to the rest of the industry. CXW outperforms 55.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CXW is significantly below the industry average of 10.78%.
The last Return On Invested Capital (5.45%) for CXW is above the 3 year average (4.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROIC 5.45%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

CXW's Profit Margin of 5.21% is fine compared to the rest of the industry. CXW outperforms 67.86% of its industry peers.
CXW's Profit Margin has declined in the last couple of years.
The Operating Margin of CXW (10.39%) is better than 72.62% of its industry peers.
CXW's Operating Margin has declined in the last couple of years.
CXW has a Gross Margin of 24.70%. This is in the lower half of the industry: CXW underperforms 63.10% of its industry peers.
CXW's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CXW is destroying value.
The number of shares outstanding for CXW has been reduced compared to 1 year ago.
CXW has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CXW has an improved debt to assets ratio.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that CXW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CXW (1.70) is worse than 61.90% of its industry peers.
CXW has a debt to FCF ratio of 5.98. This is a neutral value as CXW would need 5.98 years to pay back of all of its debts.
CXW has a Debt to FCF ratio of 5.98. This is in the better half of the industry: CXW outperforms 66.67% of its industry peers.
CXW has a Debt/Equity ratio of 0.68. This is a neutral value indicating CXW is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.68, CXW is in line with its industry, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Altman-Z 1.7
ROIC/WACC0.65
WACC8.4%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.60 indicates that CXW should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.60, CXW is in line with its industry, outperforming 55.95% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that CXW should not have too much problems paying its short term obligations.
CXW has a better Quick ratio (1.60) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.33% over the past year.
Measured over the past years, CXW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.17% on average per year.
CXW shows a small growth in Revenue. In the last year, the Revenue has grown by 1.62%.
Measured over the past years, CXW shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%

3.2 Future

Based on estimates for the next years, CXW will show a very strong growth in Earnings Per Share. The EPS will grow by 60.82% on average per year.
Based on estimates for the next years, CXW will show a quite strong growth in Revenue. The Revenue will grow by 10.41% on average per year.
EPS Next Y92.07%
EPS Next 2Y60.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9%
Revenue Next 2Y10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.88, the valuation of CXW can be described as rather expensive.
61.90% of the companies in the same industry are more expensive than CXW, based on the Price/Earnings ratio.
CXW is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.18 indicates a correct valuation of CXW.
Based on the Price/Forward Earnings ratio, CXW is valued a bit cheaper than 79.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.81. CXW is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.88
Fwd PE 13.18
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CXW's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CXW is cheaper than 70.24% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXW is valued cheaper than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.03
EV/EBITDA 9.35
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CXW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CXW's earnings are expected to grow with 60.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y60.82%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CXW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORECIVIC INC

NYSE:CXW (8/22/2025, 8:04:00 PM)

After market: 20.46 -0.33 (-1.59%)

20.79

+0.34 (+1.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners89.21%
Inst Owner Change-1.21%
Ins Owners1.91%
Ins Owner Change-3.36%
Market Cap2.23B
Analysts82.22
Price Target31.54 (51.71%)
Short Float %2.96%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.38%
Min EPS beat(2)78.22%
Max EPS beat(2)84.54%
EPS beat(4)4
Avg EPS beat(4)86.21%
Min EPS beat(4)68.32%
Max EPS beat(4)113.77%
EPS beat(8)6
Avg EPS beat(8)43.4%
EPS beat(12)9
Avg EPS beat(12)30.73%
EPS beat(16)10
Avg EPS beat(16)21.5%
Revenue beat(2)2
Avg Revenue beat(2)3.98%
Min Revenue beat(2)1.11%
Max Revenue beat(2)6.86%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.11%
Max Revenue beat(4)6.86%
Revenue beat(8)7
Avg Revenue beat(8)2.28%
Revenue beat(12)7
Avg Revenue beat(12)0.98%
Revenue beat(16)7
Avg Revenue beat(16)0.19%
PT rev (1m)0%
PT rev (3m)1.37%
EPS NQ rev (1m)20.29%
EPS NQ rev (3m)45.46%
EPS NY rev (1m)24.96%
EPS NY rev (3m)38.62%
Revenue NQ rev (1m)4.36%
Revenue NQ rev (3m)7.45%
Revenue NY rev (1m)3.73%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 21.88
Fwd PE 13.18
P/S 1.11
P/FCF 13.03
P/OCF 8.18
P/B 1.51
P/tB 1.51
EV/EBITDA 9.35
EPS(TTM)0.95
EY4.57%
EPS(NY)1.58
Fwd EY7.59%
FCF(TTM)1.6
FCFY7.67%
OCF(TTM)2.54
OCFY12.22%
SpS18.66
BVpS13.8
TBVpS13.76
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROCE 7.5%
ROIC 5.45%
ROICexc 5.72%
ROICexgc 5.73%
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
FCFM 8.55%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Debt/EBITDA 3.02
Cap/Depr 80.43%
Cap/Sales 5.06%
Interest Coverage 2.77
Cash Conversion 81.6%
Profit Quality 164.18%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.7
F-Score8
WACC8.4%
ROIC/WACC0.65
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
EPS Next Y92.07%
EPS Next 2Y60.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%
Revenue Next Year9%
Revenue Next 2Y10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.68%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year91.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.59%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y46.88%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%